America in Transition Pages

Tuesday, June 7, 2016

FDA Advisors OK Abuse-Deterrent Opioid, Despite Concerns

(MedPage Today) -- Panel backs Vantrela but wants better outcome measures for product class

from MedPage Today Washington Watch http://ift.tt/1YduqNZ
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)